v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Treasury Stock, Common
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024   258.2          
Beginning balance (in shares) at Dec. 31, 2024     (82.1)        
Beginning balance at Dec. 31, 2024 $ 6,067 $ 3 $ (10,103) $ 11,140 $ 6,065 $ (1,038) $ 0
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock (in shares)   0.3          
Issuance of common stock (35)     (35)      
Repurchase of common stock (in shares)     (2.3)        
Repurchase of common stock, net of tax (429)   $ (429)        
Stock-based compensation 65     65      
Acquisitions related noncontrolling interests 8           8
Net income 249       249   0
Unrealized losses on derivative instruments, net of tax (17)         (17)  
Defined benefit plan adjustments, net of income tax (benefit) of $—, $(1), $(1), $(1) (3)         (3)  
Foreign currency translation, net of tax 79         79  
Reclassification adjustments, net of tax 1         1  
Ending balance (in shares) at Mar. 31, 2025   258.5          
Ending balance (in shares) at Mar. 31, 2025     (84.4)        
Ending balance at Mar. 31, 2025 5,985 $ 3 $ (10,532) 11,170 6,314 (978) 8
Beginning balance (in shares) at Dec. 31, 2024   258.2          
Beginning balance (in shares) at Dec. 31, 2024     (82.1)        
Beginning balance at Dec. 31, 2024 6,067 $ 3 $ (10,103) 11,140 6,065 (1,038) 0
Increase (Decrease) in Stockholders' Equity              
Net income 515            
Unrealized losses on derivative instruments, net of tax (21)            
Defined benefit plan adjustments, net of income tax (benefit) of $—, $(1), $(1), $(1) (3)            
Foreign currency translation, net of tax 181            
Ending balance (in shares) at Jun. 30, 2025   258.5          
Ending balance (in shares) at Jun. 30, 2025     (88.5)        
Ending balance at Jun. 30, 2025 5,786 $ 3 $ (11,145) 11,222 6,580 (882) 8
Beginning balance (in shares) at Mar. 31, 2025   258.5          
Beginning balance (in shares) at Mar. 31, 2025     (84.4)        
Beginning balance at Mar. 31, 2025 5,985 $ 3 $ (10,532) 11,170 6,314 (978) 8
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock 0            
Repurchase of common stock (in shares)     (4.1)        
Repurchase of common stock, net of tax (613)   $ (613)        
Stock-based compensation 52     52      
Net income 266       266   0
Unrealized losses on derivative instruments, net of tax (4)         (4)  
Defined benefit plan adjustments, net of income tax (benefit) of $—, $(1), $(1), $(1) 0            
Foreign currency translation, net of tax 102         102 0
Reclassification adjustments, net of tax (2)         (2)  
Ending balance (in shares) at Jun. 30, 2025   258.5          
Ending balance (in shares) at Jun. 30, 2025     (88.5)        
Ending balance at Jun. 30, 2025 $ 5,786 $ 3 $ (11,145) 11,222 6,580 (882) 8
Beginning balance (in shares) at Dec. 31, 2025 169.6 259.1          
Beginning balance (in shares) at Dec. 31, 2025 (89.5)   (89.5)        
Beginning balance at Dec. 31, 2025 $ 6,630 $ 3 $ (11,357) 11,375 7,425 (943) 127
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock (in shares)   0.5          
Issuance of common stock (40)     (40)      
Repurchase of common stock (in shares)     (3.2)        
Repurchase of common stock, net of tax (557)   $ (557)        
Stock-based compensation 66     66      
Net income 275       274   1
Defined benefit plan adjustments, net of income tax (benefit) of $—, $(1), $(1), $(1) 1         1  
Foreign currency translation, net of tax (33)         (33)  
Reclassification adjustments, net of tax 7         7  
Ending balance (in shares) at Mar. 31, 2026   259.6          
Ending balance (in shares) at Mar. 31, 2026     (92.7)        
Ending balance at Mar. 31, 2026 $ 6,349 $ 3 $ (11,914) 11,401 7,699 (968) 128
Beginning balance (in shares) at Dec. 31, 2025 169.6 259.1          
Beginning balance (in shares) at Dec. 31, 2025 (89.5)   (89.5)        
Beginning balance at Dec. 31, 2025 $ 6,630 $ 3 $ (11,357) 11,375 7,425 (943) 127
Increase (Decrease) in Stockholders' Equity              
Net income 533            
Unrealized losses on derivative instruments, net of tax 11            
Defined benefit plan adjustments, net of income tax (benefit) of $—, $(1), $(1), $(1) 0            
Foreign currency translation, net of tax $ (42)            
Ending balance (in shares) at Jun. 30, 2026 164.6 259.6          
Ending balance (in shares) at Jun. 30, 2026 (95.0)   (95.0)        
Ending balance at Jun. 30, 2026 $ 6,301 $ 3 $ (12,316) 11,493 7,955 (964) 130
Beginning balance (in shares) at Mar. 31, 2026   259.6          
Beginning balance (in shares) at Mar. 31, 2026     (92.7)        
Beginning balance at Mar. 31, 2026 6,349 $ 3 $ (11,914) 11,401 7,699 (968) 128
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock (1)     (1)      
Repurchase of common stock (in shares)     (2.3)        
Repurchase of common stock, net of tax (402)   $ (402)        
Stock-based compensation 93     93      
Net income 258       256    
Unrealized losses on derivative instruments, net of tax 11         11  
Defined benefit plan adjustments, net of income tax (benefit) of $—, $(1), $(1), $(1) (1)         (1)  
Foreign currency translation, net of tax (9)         (9)  
Reclassification adjustments, net of tax $ 3         3  
Ending balance (in shares) at Jun. 30, 2026 164.6 259.6          
Ending balance (in shares) at Jun. 30, 2026 (95.0)   (95.0)        
Ending balance at Jun. 30, 2026 $ 6,301 $ 3 $ (12,316) $ 11,493 $ 7,955 $ (964) $ 130